Complete revascularization reduces adverse outcomes in patients with multivessel coronary artery disease

Table 1 Studies included in meta-analysis

Ref.	Type of search	Method of revascularization	Study design	Year	Definition of CR used	Follow-up (yr)
Bell et al[24]	Hand	PCI	Post hoc analysis, non-RCT	1990	Anatomical	2.2
Approach/catherine Mclellan et al[25]	Hand	PCI	Post hoc analysis, non-RCT	2005	Anatomical	9
ARTS II/Sarno et al[26]	PubMed	CABG/PCI	Post hoc analysis, non-RCT	2010	Anatomical	5
ARTS trial/van den Brand et al[14]	PubMed	CABG/PCI	Post hoc analysis, RCT	2002	Anatomical	1
SYNTAX trial/Farooq et al[27]	PubMed	CABG/PCI	Post hoc analysis, RCT	2013	Anatomical	4
BARI/Bourassa et al[28]	PubMed	CABG/PCI	Post hoc analysis, RCT	1999	Anatomical	5
Bourassa et al[29]	Hand	PTCA	Post hoc analysis, non-RCT	1998	Anatomical	9
Head et al[30]	PubMed	CABG/PCI	Post hoc analysis, RCT	2012	Anatomical	3
BARI 2D/Schwartz et al[31]	PubMed	CABG/PCI	Post hoc analysis, non-RCT	2012	Numerical	5.3
Mohammadi et al[32]	Hand	CABG	Post hoc analysis, non-RCT	2012	Anatomical	5.4 ± 3.0

CABG: Coronary artery bypass grafting; PCI: Percutaneous coronary intervention; CR: Complete revascularization; RCT: Randomly controlled trial.

Table 2 Characteristics of patients undergoing complete revascularization

Ref.	Prevalence of CR (%)	Mean age (yr)	Previous MI	No previous MI	Diabetes	No diabetes	Hypertension	No hypertension
Bell et al[24]	41.0	60.0	122	234	46	319	148	217
Approach/catherine Mclellan et al[25]	66.9	62.1	802	506	244.6	1063.4	725.94	582.06
ARTS II/Sarno et al[26]	72.5	61.5	149	688	163	674	440	397
ARTS trial/van den Brand et al[14]	77.2	61.0	385	498	143.93	739.07	-
SYNTAX trial/Farooq et al[27]	61.8	65.3	521	1088	429.6	1179.4	759.45	849.55
BARI/Bourassa et al[28]	65.4	61.3	612	584	204.52	991.48	578.86	617.14
Bourassa et al[29]	17.4	56.6	62	70	15.05	116.95	55.97	76.03
Head et al[30]	59.9	64.9	328	713	300	438	702	356
BARI 2D/Schwartz et al[31]	37.9	61.21	-		-		-
Mohammadi et al[32]	82.1	82.1	224	167	107.92	283.08	286.21	104.79

CR: Complete revascularization; MI: Myocardial infarction.

Table 3 Characteristics of patients undergoing incomplete revascularization

Ref.	Prevalence of CR (%)	Mean age (yr)	Previous MI	No previous MI	Diabetes	No diabetes	Hypertension	No hypertension
Bell et al[24]	41.0	60.0	122	234	46	319	148	217
Approach/catherine Mclellan et al[25]	66.9	62.1	802	506	244.6	1063.4	725.94	582.06
ARTS II/Sarno et al[26]	72.5	61.5	149	688	163	674	440	397
ARTS trial/van den Brand et al[14]	77.2	61.0	385	498	143.93	739.07	-
SYNTAX trial/Farooq et al[27]	61.8	65.3	521	1088	429.6	1179.4	759.45	849.55
BARI/Bourassa et al[28]	65.4	61.3	612	584	204.52	991.48	578.86	617.14
Bourassa et al[29]	17.4	56.6	62	70	15.05	116.95	55.97	76.03
Head et al[30]	59.9	64.9	328	713	300	438	702	356
BARI 2D/Schwartz et al[31]	37.9	61.21	-		-		-
Mohammadi et al[32]	82.1	82.1	224	167	107.92	283.08	286.21	104.79

CR: Complete revascularization; MI: Myocardial infarction.